The global anatomic pathology market size is calculated at USD 38.55 billion in 2025 and is forecasted to reach around USD 81.03 billion by 2034, accelerating at a CAGR of 8.62% from 2025 to 2034. The North America anatomic pathology market size surpassed USD 15.96 billion in 2024 and is expanding at a CAGR of 8.65% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Anatomic Pathology Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Anatomic Pathology Market Revenue and Volume, by Product & Services
8.1.1 Instruments
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Consumables
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Services
8.1.3.1. Market Revenue and Volume Forecast
9.1. Anatomic Pathology Market Revenue and Volume, by Application
9.1.1. Disease Diagnosis
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Drug Discovery and Development
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Others
9.1.3.1. Market Revenue and Volume Forecast
10.1. Anatomic Pathology Market Revenue and Volume, by End-use
10.1.1. Hospitals
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Research Laboratories
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Diagnostic Laboratories
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Others
10.1.4.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Product & Services
11.1.2. Market Revenue and Volume Forecast, by Application
11.1.3. Market Revenue and Volume Forecast, by End-use
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Product & Services
11.1.4.2. Market Revenue and Volume Forecast, by Application
11.1.4.3. Market Revenue and Volume Forecast, by End-use
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Product & Services
11.1.5.2. Market Revenue and Volume Forecast, by Application
11.1.5.3. Market Revenue and Volume Forecast, by End-use
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Product & Services
11.2.2. Market Revenue and Volume Forecast, by Application
11.2.3. Market Revenue and Volume Forecast, by End-use
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Product & Services
11.2.4.2. Market Revenue and Volume Forecast, by Application
11.2.4.3. Market Revenue and Volume Forecast, by End-use
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Product & Services
11.2.5.2. Market Revenue and Volume Forecast, by Application
11.2.5.3. Market Revenue and Volume Forecast, by End-use
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Product & Services
11.2.6.2. Market Revenue and Volume Forecast, by Application
11.2.6.3. Market Revenue and Volume Forecast, by End-use
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Product & Services
11.2.7.2. Market Revenue and Volume Forecast, by Application
11.2.7.3. Market Revenue and Volume Forecast, by End-use
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Product & Services
11.3.2. Market Revenue and Volume Forecast, by Application
11.3.3. Market Revenue and Volume Forecast, by End-use
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Product & Services
11.3.4.2. Market Revenue and Volume Forecast, by Application
11.3.4.3. Market Revenue and Volume Forecast, by End-use
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Product & Services
11.3.5.2. Market Revenue and Volume Forecast, by Application
11.3.5.3. Market Revenue and Volume Forecast, by End-use
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Product & Services
11.3.6.2. Market Revenue and Volume Forecast, by Application
11.3.6.3. Market Revenue and Volume Forecast, by End-use
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Product & Services
11.3.7.2. Market Revenue and Volume Forecast, by Application
11.3.7.3. Market Revenue and Volume Forecast, by End-use
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Product & Services
11.4.2. Market Revenue and Volume Forecast, by Application
11.4.3. Market Revenue and Volume Forecast, by End-use
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Product & Services
11.4.4.2. Market Revenue and Volume Forecast, by Application
11.4.4.3. Market Revenue and Volume Forecast, by End-use
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Product & Services
11.4.5.2. Market Revenue and Volume Forecast, by Application
11.4.5.3. Market Revenue and Volume Forecast, by End-use
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Product & Services
11.4.6.2. Market Revenue and Volume Forecast, by Application
11.4.6.3. Market Revenue and Volume Forecast, by End-use
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Product & Services
11.4.7.2. Market Revenue and Volume Forecast, by Application
11.4.7.3. Market Revenue and Volume Forecast, by End-use
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Product & Services
11.5.2. Market Revenue and Volume Forecast, by Application
11.5.3. Market Revenue and Volume Forecast, by End-use
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Product & Services
11.5.4.2. Market Revenue and Volume Forecast, by Application
11.5.4.3. Market Revenue and Volume Forecast, by End-use
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Product & Services
11.5.5.2. Market Revenue and Volume Forecast, by Application
11.5.5.3. Market Revenue and Volume Forecast, by End-use
12.1. Danaher
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. PHC Holdings Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Quest Diagnostics Incorporated
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Cardinal Health
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Sakura Finetek USA, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. NeoGenomics Laboratories, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. BioGenex
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Bio SB
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Laboratory Corporation of America Holdings
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. F. Hoffmann-La Roche AG
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample